NEW YORK, NY / ACCESS Newswire / April 15, 2025 / If you suffered a loss on your AppLovin Corporation (NASDAQ:APP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applovin-corporation-lawsuit-submission-form?prid=143131&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / April 15, 2025 / If you suffered a loss on your Ready Capital Corporation (NYSE:RC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ready-capital-corporation-lawsuit-submission-form?prid=143132&wire=1 or contact Joseph E. Levi, Esq.

NORTHVILLE, Mich. , April 15, 2025 /PRNewswire/ -- Cooper-Standard Holdings Inc. (NYSE: CPS) expects to release its financial results for the first quarter 2025 on Thursday, May 1 after market close.

NEW YORK, NY / ACCESS Newswire / April 15, 2025 / If you suffered a loss on your Constellation Brands, Inc. (NYSE:STZ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/constellation-brands-inc-lawsuit-submission-form?prid=143130&wire=1 or contact Joseph E. Levi, Esq.

The JPMorgan Equity Premium Income ETF offers an 8% yield by combining stocks with a call writing strategy for income generation. JEPI's portfolio includes leading U.S. companies like Visa, Mastercard, McDonald's, Microsoft, and Amazon, providing defensive equity exposure. The JPMorgan Equity Premium Income ETF has a well-diversified equity portfolio and the ETF's yield has recently spiked above its longer term average yield, indicating undervaluation.

Johnson & Johnson (NYSE:JNJ) reported its first quarter earnings, with both revenue and profit beating Wall Street expectations driven by strong sales in its oncology portfolio, especially the multiple myeloma drug Darzalex. Revenue was up 2.4% year-over-year at $21.89 billion, ahead of estimates of $21.56 billion.

BMI's performance is likely to have benefited from demand for its solutions. However, the uncertain macro backdrop, higher costs and competition are concerns.

Investors need to pay close attention to Pentair (PNR) stock based on the movements in the options market lately.

She co-founded Wynn Resorts with her ex-husband and was the largest individual shareholder.

Diageo PLC (LSE:DGE) and Burberry Group PLC (LSE:BRBY) face headwinds ahead, analysts said as they read across from a trading update from luxury giant Louis Vuitton Moet Hennessy (EPA:MC). As well as making Johnnie Walker and Crown Royal whiskey, Smirnoff and Ciroc vodka, Diageo also has a 34% stake in LVMH's Wine & Spirits division.

Nvidia Corporation faces significant trade uncertainties due to fluctuating tariffs and the impending AI Diffusion Rule, impacting its semiconductor exports and overall growth outlook. Despite these challenges, NVDA stock's valuation remains attractive, with projected FY26 revenue growth of 56% and EPS growth of 51%, trading at a forward P/E of 24.5x. The next 30 days are crucial for Nvidia to negotiate with the U.S. administration to potentially amend the AI Diffusion IFR and mitigate trade impacts.

SYDNEY , April 15, 2025 /PRNewswire/ -- Omni Bridgeway (ASX: OBL) and funds managed by Ares Management Corporation (NYSE: ARES) have completed a strategic transaction establishing a continuation fund (Omni Bridgeway Fund 9). Omni Bridgeway Fund 9 purchased Omni Bridgeway's co-investment interest across a diversified global portfolio of more than 150 legal assets, originated and managed by Omni Bridgeway.

Investors need to pay close attention to Independent Bank (INDB) stock based on the movements in the options market lately.

Increasing demand bodes well for RADCOM, but higher costs, execution risks, geopolitical tension and forex exposure remain overhangs.

I am bullish on Cameco due to its strong uranium production capacity and market dominance in the Western region, despite reduced production guidance. Cameco's strategic contracts to sell 220 million pounds of uranium to 41 global customers, with a significant focus on Western markets, bolster its bullish potential. The company's strong financials, including a significant increase in adjusted EBITDA and a robust balance sheet, highlight its solid financial health and growth prospects.

Arcos Dorados continues to grow its share by focusing on affordability platforms and value-driven menus. Yet, uncertain macro conditions ail.

LOS ANGELES , April 15, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ: MRVI) for violations of the federal securities laws. Shareholders who purchased the Company's securities between August 7, 2024 and February 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before May 5, 2025.

LOS ANGELES , April 15, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Geron Corporation ("Geron" or "the Company") (NASDAQ: GERN) for violations of the federal securities laws. Shareholders who purchased the Company's securities between June 7, 2024 and February 25, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before May 12, 2025.

LOS ANGELES , April 15, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Fluence Energy, Inc. ("Fluence" or "the Company") (NASDAQ: FLNC) for violations of the federal securities laws. Shareholders who purchased the Company's securities between November 29, 2023, and February 10, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before May 12, 2025.

In my 2025 Outlook, I picked AbbVie Pharmaceuticals (NYSE: ABBV) as one to watch this year. Here is what I wrote: AbbVie (ABBV) AbbVie primarily works in immunology, oncology, neuroscience, eye care, and virology.